Emil Pharmaceuticals

Emil Pharmaceuticals

SectorPharmaceuticals
StatusCurrent
Year of investment2023
LocationMumbai, Maharashtra

Manufacturer of Pharmaceutical Formulations for Multinational Corporations

Founded in 1989 by technocrats with a vision to manufacture quality medicines, Emil Pharma started with one GMP Unit set up in Tarapur Mumbai. For business expansion, the Group acquired Medibios – a manufacturing plant located within close proximity in 1996. Currently, they have two units, with unparalleled quality standards, manufacturing for multinational giants like Pfizer, Merck, Glaxo Smith Kline, Abbot Laboratories, Wockhardt, Glenmark Pharmaceuticals, US Vitamins, Novartis. The Company has the technical know-how for 200+ formulations across 30 therapeutic categories. Their products have reached most international markets in South & Central America like (Chile, Peru, Venezuela, Suriname, El Salvador, Ecuador, Panama and others), African Countries (like Nigeria, Ghana, South Africa and others), Southeast Asian Countries (like Vietnam, Srilanka, Myanmar, Malaysia, Philippines and others) and some CIS nations. The Group manufactures and sells pharmaceutical products through Contact Manufacturing for Third Party and under Loan and License Arrangements and through their own branding. Over the past three decades the Group has-

  • Built reputation as a reliable Contract Manufacturer providing quality and integrity to its customers.
  • Emerged as globally focused organization, manufacturing variety of ethical formulations for human care.
  • Manufactures products on par with international quality which is proven by Bio-equivalence studies.
  • Well entrenched among Multinational and Large Indian Corporates offering the below advantages-
    • Exposure to Quality Systems developed a culture amongst staff and workers, of following GMP standards.
    • Bulk production requirements lead to continuous growth by way of capacity utilization and expansion.
    • Adoption of international production standards supports exports of group’s own products.

ESG & Impact

The Company has set up an in-house Effluent Treatment Plant (ETP) for waste treatment as mandated by MPCB.

  • Air Pollution is only due to the Boiler, which is maintained regularly to ensure efficient combustion of fuels (LDO).
  • Gases let out from tablet coating operations are passed through scrubber to strip off the solvents.
  • Scrubber Effluents are let into ETP for in-house treatment.
  • Plastics including PVC foils are sent for Recycling.Cartons/Boxes are sold as scrap after shredding.
  • Aluminum Foils are punctured and then sold as scrap.
  • Expired raw materials/ finished goods are sent for incineration to Government nominated agency at Taloja.
    • Donations to Educational Institutes like IIT Bombay, IIT Gandhinagar, Ram Bajaj Foundation, SEWA Rural- society for Education, Welfare & Action Rural, etc.
    • Donations for promoting Healthcare Organizations-
    • ANJALI- Society for Rural Health and Development, taking care of poor and
      underprivileged people.
    • SAREX Foundation- for Oxygen Cylinders during Covid etc.
  • Donated Funds to CM Relief Fund during Covid.